Cargando…
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry
BACKGROUND: Use of rate/rhythm control is essential to control symptoms in patients with atrial fibrillation (AF). Recently, the EAST-AFNET 4 trial described how early rhythm control strategy was associated with a lower risk of adverse clinical outcomes. OBJECTIVES: The aim was to evaluate the real-...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766399/ https://www.ncbi.nlm.nih.gov/pubmed/34448931 http://dx.doi.org/10.1007/s00392-021-01914-y |
_version_ | 1784634521352667136 |
---|---|
author | Proietti, Marco Vitolo, Marco Harrison, Stephanie L. Lane, Deirdre A. Fauchier, Laurent Marin, Francisco Nabauer, Michael Potpara, Tatjana S. Dan, Gheorghe-Andrei Boriani, Giuseppe Lip, Gregory Y. H. |
author_facet | Proietti, Marco Vitolo, Marco Harrison, Stephanie L. Lane, Deirdre A. Fauchier, Laurent Marin, Francisco Nabauer, Michael Potpara, Tatjana S. Dan, Gheorghe-Andrei Boriani, Giuseppe Lip, Gregory Y. H. |
author_sort | Proietti, Marco |
collection | PubMed |
description | BACKGROUND: Use of rate/rhythm control is essential to control symptoms in patients with atrial fibrillation (AF). Recently, the EAST-AFNET 4 trial described how early rhythm control strategy was associated with a lower risk of adverse clinical outcomes. OBJECTIVES: The aim was to evaluate the real-world applicability and impact of an early rhythm control strategy in patients with AF. METHODS: Use of an early rhythm control strategy was assessed in a European cohort of AF patients derived from the EHRA-ESC EORP-AF General Long-Term Registry. Early rhythm control was defined as use of antiarrhythmic drugs or cardioversion/catheter ablation. The primary outcome included cardiovascular death, stroke, acute coronary syndrome, and worsening of heart failure. Quality of life and health-care resource usage were also assessed as outcomes. RESULTS: Among the 10,707 patients evaluated for eligibility to EAST-AFNET 4, a total of 3774 (34.0%) were included. Early rhythm control was associated with better quality of life, but with greater use of health-care resources. During follow-up, the primary outcome occurred less often in early rhythm control patients than in those with no rhythm control (13.6% vs. 18.5%, p < 0.001). In the multivariate adjusted Cox regression model, no significant difference was found between no rhythm control and early rhythm control, for the primary outcome. No difference in the primary outcome between early rhythm control and ‘no rhythm control patients’ adherent to Atrial fibrillation Better Care (ABC) pathway’ was evident (p = 0.753) CONCLUSIONS: Use of an early rhythm control strategy was associated with a lower rate of major adverse events, but this difference was non-significant on multivariate analysis, being mediated by differences in baseline characteristics and clinical risk profile. Early rhythm control was associated with a higher use of health-care resources and risk of hospital admission, despite showing better quality of life. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-021-01914-y. |
format | Online Article Text |
id | pubmed-8766399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-87663992022-02-02 Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry Proietti, Marco Vitolo, Marco Harrison, Stephanie L. Lane, Deirdre A. Fauchier, Laurent Marin, Francisco Nabauer, Michael Potpara, Tatjana S. Dan, Gheorghe-Andrei Boriani, Giuseppe Lip, Gregory Y. H. Clin Res Cardiol Original Paper BACKGROUND: Use of rate/rhythm control is essential to control symptoms in patients with atrial fibrillation (AF). Recently, the EAST-AFNET 4 trial described how early rhythm control strategy was associated with a lower risk of adverse clinical outcomes. OBJECTIVES: The aim was to evaluate the real-world applicability and impact of an early rhythm control strategy in patients with AF. METHODS: Use of an early rhythm control strategy was assessed in a European cohort of AF patients derived from the EHRA-ESC EORP-AF General Long-Term Registry. Early rhythm control was defined as use of antiarrhythmic drugs or cardioversion/catheter ablation. The primary outcome included cardiovascular death, stroke, acute coronary syndrome, and worsening of heart failure. Quality of life and health-care resource usage were also assessed as outcomes. RESULTS: Among the 10,707 patients evaluated for eligibility to EAST-AFNET 4, a total of 3774 (34.0%) were included. Early rhythm control was associated with better quality of life, but with greater use of health-care resources. During follow-up, the primary outcome occurred less often in early rhythm control patients than in those with no rhythm control (13.6% vs. 18.5%, p < 0.001). In the multivariate adjusted Cox regression model, no significant difference was found between no rhythm control and early rhythm control, for the primary outcome. No difference in the primary outcome between early rhythm control and ‘no rhythm control patients’ adherent to Atrial fibrillation Better Care (ABC) pathway’ was evident (p = 0.753) CONCLUSIONS: Use of an early rhythm control strategy was associated with a lower rate of major adverse events, but this difference was non-significant on multivariate analysis, being mediated by differences in baseline characteristics and clinical risk profile. Early rhythm control was associated with a higher use of health-care resources and risk of hospital admission, despite showing better quality of life. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-021-01914-y. Springer Berlin Heidelberg 2021-08-27 2022 /pmc/articles/PMC8766399/ /pubmed/34448931 http://dx.doi.org/10.1007/s00392-021-01914-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Proietti, Marco Vitolo, Marco Harrison, Stephanie L. Lane, Deirdre A. Fauchier, Laurent Marin, Francisco Nabauer, Michael Potpara, Tatjana S. Dan, Gheorghe-Andrei Boriani, Giuseppe Lip, Gregory Y. H. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry |
title | Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry |
title_full | Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry |
title_fullStr | Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry |
title_full_unstemmed | Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry |
title_short | Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry |
title_sort | real-world applicability and impact of early rhythm control for european patients with atrial fibrillation: a report from the esc-ehra eorp-af long-term general registry |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766399/ https://www.ncbi.nlm.nih.gov/pubmed/34448931 http://dx.doi.org/10.1007/s00392-021-01914-y |
work_keys_str_mv | AT proiettimarco realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT vitolomarco realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT harrisonstephaniel realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT lanedeirdrea realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT fauchierlaurent realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT marinfrancisco realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT nabauermichael realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT potparatatjanas realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT dangheorgheandrei realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT borianigiuseppe realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT lipgregoryyh realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry AT realworldapplicabilityandimpactofearlyrhythmcontrolforeuropeanpatientswithatrialfibrillationareportfromtheescehraeorpaflongtermgeneralregistry |